Business Context and Reporting Period
This Form 8-K is a current report filed by International Flavors & Fragrances Inc. (IFF) on February 20, 2025. The filing addresses Item 5.02 regarding the departure of a senior officer and the appointment of a successor within the Health & Biosciences division.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
- Departure: Simon Herriott, currently President of Health & Biosciences, will leave IFF on March 31, 2025.
- Severance: Mr. Herriott's departure is classified as a qualifying event under IFF's executive severance policy.
- Appointment: Leticia Goncalves Lourenço will join IFF as President of the Health & Biosciences division, effective March 1, 2025.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding financial guidance, future outlook, specific risks, contingencies, or unusual items. The document is limited to the announcement of the leadership transition.
Investor Verification Checklist
- Verify the specific terms of the executive severance policy applicable to Simon Herriott's departure.
- Confirm the transition timeline between Mr. Herriott's exit (March 31) and Ms. Lourenço's start date (March 1).
- Review subsequent filings for any financial impact related to the severance payment.